Search

Search Constraints

Start Over Filtering by: Keyword vaccines Remove constraint Keyword: vaccines

Search Results

  • Hypothesis testing and sample size considerations for the test-negative design
  • Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report
  • Understanding caregivers' decision to vaccinate childhood cancer survivors against COVID‐19
  • Vaccine induced memory CD8+ T cells efficiently prevent viral transmission from the respiratory tract
  • Corrigendum: LetsTalkShots: personalized vaccine risk communication
  • Modeling the use of SARS-CoV-2 vaccination to safely relax non-pharmaceutical interventions
  • Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
  • Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study.
  • Efficacy of a Pseudomonas aeruginosa Serogroup O9 Vaccine.
  • Virology under the Microscope—a Call for Rational Discourse
  • LetsTalkShots: personalized vaccine risk communication
  • COVID-19 Vaccination Clinic for Individuals With Autism Spectrum Disorder and Related Disorders: Feasibility and Acceptability
  • Transporting monovalent rotavirus vaccine efficacy estimates to an external target population: a secondary analysis of data from a randomised controlled trial in Malawi
  • Vaccines against Emerging and Neglected Infectious Diseases: An Overview
  • Virology under the Microscope-a Call for Rational Discourse
  • Virology under the Microscope-a Call for Rational Discourse
  • The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks
  • Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
  • Triumphs of Immunization
  • Functional Features of the Respiratory Syncytial Virus G Protein
  • Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials
  • Assessing trends in vaccine efficacy by pathogen genetic distance.
  • Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
  • Accuracy of influenza vaccination rate estimates in United States nursing home residents
  • Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
  • Vaccine safety: looking forward and back
  • Vaccine safety issues at the turn of the 21st century
  • COVID-19 Diagnostics, Tools, and Prevention
  • Health spending and vaccination coverage in low-income countries
  • VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
  • Reduced SARS-CoV-2 Vaccine Response in Patients Treated with Biologic Therapies for Asthma and Atopic Dermatitis
  • COVID-19 Vaccine Hesitancy Among Healthcare Workers in Four Healthcare Systems in Atlanta
  • Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response.
  • Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
  • Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi
  • Characterizing the vaccine knowledge, attitudes, beliefs, and intentions of pregnant women in Georgia and Colorado
  • Harnessing Cross-Reactive CD8(+) T-RM Cells for Long-Standing Protection Against Influenza A Virus
  • Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination
  • CXCL13 is a plasma biomarker of germinal center activity
  • Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era
  • Mathematical modeling provides kinetic details of the human immune response to vaccination
  • Febrile Seizure Risk after Vaccination in Children One to Five Months of Age
  • Timing of Birth as an Emergent Risk Factor for Rotavirus Hospitalization and Vaccine Performance in the Postvaccination Era in the United States
  • Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
  • Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
  • Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
  • Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children
  • Engineering nanoparticles to overcome barriers to immunotherapy
  • Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective
  • Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer
  • Are Recent Medical Graduates More Skeptical of Vaccines?
  • RNA Virus Reverse Genetics and Vaccine Design